Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accreted, Blvd, borrowed, choose, concurrently, default, discretionary, foreseeable, guaranty, indemnify, Indemnity, mandatory, Pledged, prepayment, protection, response, revaluation, standard, Suite, today, twelve
Removed:
capitalized, convertible, letter, machinery, media, million, private, recently, unsecured
Filing tables
Filing exhibits
ECTE similar filings
Filing view
External links
Exhibit 10.4
COMMITMENT LETTER EXTENSION AGREEMENT
Reference is hereby made to the Letter Agreement dated as of August 8, 2012 (the “Letter Agreement”) between Echo Therapeutics, Inc. (“Echo”) and Platinum-Montaur Life Sciences, LLC (“Platinum”).
Upon execution by each of Echo and Platinum below, the reference to the date of the execution and delivery of definitive documentation in the Section entitled “CLOSING” in the Letter Agreement shall be deemed amended to “August 31, 2012”.
IN WITNESS WHEREOF, the parties have entered into this Commitment Letter Extension Agreement as of August 24, 2012.
ECHO THERAPEUTICS, INC.
By: /s/ Patrick Mooney
Name: Patrick Mooney
Title: CEO
PLATINUM-MONTAUR LIFE SCIENCES, LLC
By: /s/ Michael M. Goldberg, M.D.
Name: Michael M. Goldberg, M.D.
Title: ________________